Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy

• Published in: Molecular genetics and metabolism Vol. 123; no. 2; pp. 85 - 91
• Main Authors: McIntosh, Paul T., Hobson-Webb, Lisa D., Kazi, Zoheb B., Prater, Sean N., Banugaria, Suhrad G., Austin, Stephanie, Wang, Raymond, Enterline, David S., Frush, Donald P., Kishnani, Priya S.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-02-2018
• Subjects: Acid maltase deficiency; Adolescent; Alglucosidase alfa; alpha-Glucosidases - administration & dosage; Blood-brain barrier; Brain - diagnostic imaging; Central nervous system; Child; Child, Preschool; Enzyme Replacement Therapy; Female; Glycogen storage disease type II; Glycogen Storage Disease Type II - diagnostic imaging; Glycogen Storage Disease Type II - enzymology; Glycogen Storage Disease Type II - therapy; Humans; Infant; Male; MRI; Neuroimaging; Neuroimaging - methods; Neuromuscular diseases; Pompe disease; rhGAA; Treatment Outcome; Pompe disease; Neuroimaging; CT; Glycogen storage disease type II; Neuromuscular diseases; Blood-brain barrier; Alglucosidase alfa; Enzyme replacement therapy; MRI; Central nervous system; rhGAA; Acid maltase deficiency
• ISSN: 1096-7192; 1096-7206
• DOI: 10.1016/j.ymgme.2017.10.005

Recombinant human acid α-glucosidase (rhGAA) enzyme replacement therapy (ERT) has prolonged survival in infantile Pompe disease (IPD), but has unmasked central nervous system (CNS) changes.
Brain imaging, consisting of computed tomography (CT) and/or magnetic resonance imaging (MRI), was performed on 23 patients with IPD (17 CRIM-positive, 6 CRIM-negative) aged 2–38months. Most patients had baseline neuroimaging performed prior to the initiation of ERT. Follow-up neuroimaging was performed in eight.
Sixteen patients (70%) had neuroimaging abnormalities consisting of ventricular enlargement (VE) and/or extra-axial cerebrospinal fluid accumulation (EACSF) at baseline, with delayed myelination in two. Follow-up neuroimaging (n=8) after 6–153months showed marked improvement, with normalization of VE and EACSF in seven patients. Two of three patients imaged after age 10years demonstrated white matter changes, with one noted to have a basilar artery aneurysm.
Mild abnormalities on brain imaging in untreated or newly treated patients with IPD tend to resolve with time, in conjunction with ERT. However, white matter changes are emerging as seen in Patients 1 and 3 which included abnormal periventricular white matter changes with subtle signal abnormalities in the basal ganglia and minimal, symmetric signal abnormalities involving the deep frontoparietal cerebral white matter, respectively. The role of neuroimaging as part of the clinical evaluation of IPD needs to be considered to assess for white matter changes and cerebral aneurysms.